Better Medicine

Better Medicine, based in Estonia, focuses on artificial intelligence solutions for healthcare, enhancing clinical decision-making and patient outcomes through advanced data analysis. Better Medicine was founded by Priit Salumaa (CEO), Dmytro Fishman, Martin Reim, Helena Ije, Bohdan Petryshak, and Sergei Gussev, in 2020 in Tartu, Estonia, specializing in AI-driven healthcare solutions. The company has engaged in a single funding round, raising EUR 1 million in pre-seed funding on August 14, 2025, led by Soulmates Ventures, with participation from Specialist VC and UniTartu Ventures. Better Medicine AI specializes in advanced AI-driven healthcare solutions aimed at enhancing clinical decision-making and patient outcomes.

Their core offerings include machine learning algorithms that analyze medical data to provide actionable insights for healthcare professionals, streamlining diagnostics and treatment planning. The company serves hospitals, outpatient clinics, and telehealth providers across North America and Europe, focusing on innovative healthcare technologies. The revenue model for Better Medicine AI is structured primarily around subscription services and partnerships with healthcare institutions. Clients engage with the company through annual licensing agreements that provide access to their suite of AI tools and ongoing software updates.

Pricing plans are tailored to the size and needs of healthcare providers, allowing for effective integration of technology into existing systems. In August 2025, Better Medicine raised EUR 1 million in pre-seed funding, which will be used to grow operations and advance product development initiatives. The company plans to design and launch new products aimed at improving patient management systems while expanding into new markets across Europe and North America. Specific timelines for new product releases and market entry are not disclosed.